The elevated levels of IL-1β and IL-18 observed in COVID-19 patients with CRS support the involvement of the DDR and DNA sensing, via downstream inflammasome activation, amplifying inflammation and contributing to tissue injury. This evidence concerns the gene IL18 and COVID-19.